The 2017 iCarbonX-led investment in PatientsLikeMe spread over its members (money paid for part of a patient-community company, arithmetic over two stated numbers)
at least $100 million
USD invested per PatientsLikeMe member, for a part stake (a floor for the company's value per member)
“So far PatientsLikeMe has raised at least $100 million. ... The investment gives Jun Wang a minority equity position in PatientsLikeMe. ... Today more than 500,000 people use the platform to track and share information about 2,700 conditions.”
- Kind of source
- Named press report
- Read on
- 2026-11-07
- Daily check
- Quote found at the source on 2026-11-07
- What to know
- A funding round, not a sale: iCarbonX (most of the money) and Invus paid at least $100 million, partly in sequencing services at cost, for a stake in a company whose members record their conditions, symptoms and treatments with their own ratings. The stake is reported here as a minority position and by CNBC (4 April 2019) as a majority stake; no valuation was disclosed, and Optum's 2019 purchase of PatientsLikeMe was at an undisclosed price.
- Arithmetic
- $100,000,000 / 500,000 members = $200 per member. The money bought only part of the company, so this is a floor for its implied value per member; the stake size, and with it the whole value, is not public.
- About
- Your health story
Used in
Kept as evidence; no figure on the platform is computed from it yet.